Interpretation of CBC with Normal Hemoglobin, Elevated RDW, and Thrombocytopenia

Analysis of CBC Parameters

A CBC pattern with normal hemoglobin, elevated RDW, and thrombocytopenia is most consistent with early essential thrombocythemia or another myeloproliferative neoplasm, according to the American Society of Hematology 1, 2
Normal hemoglobin with normal hematocrit indicates absence of anemia, as indicated by the European Crohn's and Colitis Organisation 3
Elevated RDW suggests heterogeneity in red cell size, indicating abnormal erythropoiesis, as suggested by the American College of Physicians 4, 2
Severe thrombocytopenia with elevated MPV suggests potential bone marrow disorder or peripheral destruction, according to the American Society of Hematology 1
Normal RBC count with these other findings points toward a primary bone marrow disorder rather than a deficiency state, as indicated by the European Crohn's and Colitis Organisation 3, 4

Essential thrombocythemia or early myeloproliferative neoplasm is the most likely diagnosis, given the combination of thrombocytopenia with elevated MPV and RDW, which suggests abnormal megakaryocyte function and disordered hematopoiesis, according to the American Society of Hematology 1
Early or developing iron deficiency can present with elevated RDW before anemia develops, but would not typically cause significant thrombocytopenia, as suggested by the American College of Physicians 4, 2

A complete blood count with differential is recommended to assess white cell lineage and confirm thrombocytopenia, as indicated by the European Crohn's and Colitis Organisation 3, 4
Iron studies, including serum ferritin and transferrin saturation, are recommended to rule out iron deficiency, as suggested by the American College of Physicians 4, 2
JAK2 mutation testing is recommended to evaluate for myeloproliferative neoplasm, according to the American Society of Hematology 1
Bone marrow aspiration and biopsy are essential for definitive diagnosis, particularly to evaluate megakaryocyte morphology and cellularity, according to the American Society of Hematology 1

Hematology consultation is recommended for immediate referral for specialized evaluation, according to the American Society of Hematology 1
Avoiding antiplatelet medications is recommended due to severe thrombocytopenia, according to the American Society of Hematology 1
For myeloproliferative neoplasm, treatment according to WHO criteria and risk stratification is recommended, according to the American Society of Hematology 1
For iron deficiency, iron supplementation is recommended if confirmed, with investigation for source of blood loss, as suggested by the American College of Physicians 4

Elevated RDW with normal MCV can mask early iron deficiency or combined deficiency states, as suggested by the American College of Physicians 4
Assuming iron deficiency based solely on elevated RDW without considering other causes of abnormal erythropoiesis is a pitfall, as suggested by the American College of Physicians 4

Close monitoring of complete blood counts is recommended to assess disease progression, as suggested by the American College of Physicians 4
Repeat bone marrow examination is recommended if diagnosis remains unclear or clinical status changes, according to the American Society of Hematology 1
Long-term surveillance is recommended based on final diagnosis, according to the American Society of Hematology 1